ERBB2 and breast cancer: Using RNA-sequencing (Xentech biotechnology), we analyzed the quantity and the sequences of LRP-1 RNA in xenograft (PDX) derived from 20 breast cancer patients, including 12 TNBC and 8 non-TNBC (seven luminal and one HER2+).